CD4-independent human immunodeficiency virus infection involves participation of endocytosis and cathepsin B

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Yoshii, Hiroaki ^a,b,g   Kamiyama, Haruka ^a   Goto, Kensuke ^a   Oishi, Kazunori ^b,c   Katunuma, Nobuhiko ^d   Tanaka, Yuetsu ^e   Hayashi, Hideki ^b   Matsuyama, Toshifumi ^b   Sato, Hironori ^a,f   Yamamoto, Naoki ^a,f,h   Kubo, Yoshinao ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d TOKUSHIMA BUNRI UNIVERSITY   (Japan)

^e UNIVERSITY OF THE RYUKYUS   (Japan)

^f NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^g NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

^h NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN B; CD4 ANTIGEN; CYSTATIN C; TOLL LIKE RECEPTOR 4; VIRUS ENVELOPE PROTEIN; ACID; BAFILOMYCIN A1; CHLOROQUINE; CTSB PROTEIN, HUMAN; HYDRAZONE DERIVATIVE; MACROLIDE; N' (3,4 DIHYDROXYBENZYLIDENE) 3 HYDROXY 2 NAPHTHAHYDRAZIDE; N'-(3,4-DIHYDROXYBENZYLIDENE)-3-HYDROXY-2-NAPHTHAHYDRAZIDE; PROTEINASE INHIBITOR; TLR4 PROTEIN, HUMAN;

ACIDIFICATION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DNA SCREENING; ENDOCYTOSIS; ENDOSOME; ENZYME ACTIVITY; HELA CELL; HOST SUSCEPTIBILITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INNATE IMMUNITY; NUCLEOTIDE SEQUENCE; PH; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; VIRUS INFECTIVITY; VIRUS STRAIN; VIRUS TITRATION; CELL STRAIN HEK293; DOMINANT GENE; DRUG ANTAGONISM; DRUG EFFECT; GENE VECTOR; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; PATHOLOGY; PHYSIOLOGY; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

ACIDS; ANTIGENS, CD4; CATHEPSIN B; CHLOROQUINE; CYSTATIN C; ENDOCYTOSIS; ENDOSOMES; GENES, DOMINANT; GENETIC VECTORS; HEK293 CELLS; HELA CELLS; HIV INFECTIONS; HIV-1; HUMANS; HYDRAZONES; IMMUNITY, INNATE; MACROLIDES; PROTEASE INHIBITORS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 79955563682     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019352     Document Type: Article

References (60)

1. Gallo SA, Finnegan CM, Viard M, Raviv Y, Dimitrov A, et al. (2003) The HIV Env-mediated fusion reaction. Biochim Biophys Acta 1614: 36-50.
2. Shimizu N, Soda Y, Kanbe K, Liu HY, Mukai R, et al. (2000) A putative G protein-coupled receptor, RDC1, is a novel coreceptor for human and simian immunodeficiency viruses. J Virol 74: 619-626.
3. Chenine AL, Pion M, Matouskova E, Gondois-Rey F, Vigne R, et al. (2002) Adaptation of a CXCR4-using human immunodeficiency type 1 NDK virus in intestinal cells is associated with CD4-independent replication. Virology 304: 403-414.
4. Dumonceaux J, Nisole S, Chanel C, Quivet L, Amara A, et al. (1998) Spontaneous mutations in the env gene of the human immunodeficiency virus type 1 NDK isolate are associated with a CD4-independent entry phenotype. J Virol 72: 512-519.
5. Hoffman TL, LaBranche CC, Zhang W, Canziani G, Robinson J, et al. (1999) Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein. Proc Natl Acad Sci U S A 96: 6359-6364.
6. Xiao P, Usami O, Suzuki Y, Ling H, Shimizu N, et al. (2008) Characterization of a CD4-independent clinical HIV-1 that can efficiently infect human hepatocytes through chemokine (C-X-C motif) receptor 4. Aids 22: 1749-1757.
7. Zerhouni B, Nelson JA, Saha K, (2004) Isolation of CD4-independent primary human immunodeficiency virus type 1 isolates that are syncytium inducing and acutely cytopathic for CD8+ lymphocytes. J Virol 78: 1243-1255.
8. Saha K, Zhang J, Gupta A, Dave R, Yimen M, et al. (2001) Isolation of primary HIV-1 that target CD8+ T lymphocytes using CD8 as a receptor. Nat Med 7: 65-72.
9. Saha K, Zhang J, Zerhouni B, (2001) Evidence of productively infected CD8+ T cells in patients with AIDS: implications for HIV-1 pathogenesis. J Acquir Immune Defic Syndr 26: 199-207.
10. Marras D, Bruggeman LA, Gao F, Tanji N, Mansukhani MM, et al. (2002) Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy. Nat Med 8: 522-526.
11. Edinger AL, Blanpain C, Kunstman KJ, Wolinsky SM, Parmentier M, et al. (1999) Functional dissection of CCR5 coreceptor function through the use of CD4-independent simian immunodeficiency virus strains. J Virol 73: 4062-4073.
12. Puffer BA, Pohlmann S, Edinger AL, Carlin D, Sanchez MD, et al. (2002) CD4 independence of simian immunodeficiency virus Envs is associated with macrophage tropism, neutralization sensitivity, and attenuated pathogenicity. J Virol 76: 2595-2605.
13. Barnard RJ, Narayan S, Dornadula G, Miller MD, Young JA, (2004) Low pH is required for avian sarcoma and leukosis virus Env-dependent viral penetration into the cytosol and not for viral uncoating. J Virol 78: 10433-10441.
14. Bertrand P, Cote M, Zheng YM, Albritton LM, Liu SL, (2008) Jaagsiekte sheep retrovirus utilizes a pH-dependent endocytosis pathway for entry. J Virol 82: 2555-2559.
15. Brindley MA, Maury W, (2008) Equine infectious anemia virus entry occurs through clathrin-mediated endocytosis. J Virol 82: 1628-1637.
16. Jin S, Zhang B, Weisz OA, Montelaro RC, (2005) Receptor-mediated entry by equine infectious anemia virus utilizes a pH-dependent endocytic pathway. J Virol 79: 14489-14497.
17. McClure MO, Sommerfelt MA, Marsh M, Weiss RA, (1990) The pH independence of mammalian retrovirus infection. J Gen Virol 71 (Pt 4): 767-773.
18. Picard-Maureau M, Jarmy G, Berg A, Rethwilm A, Lindemann D, (2003) Foamy virus envelope glycoprotein-mediated entry involves a pH-dependent fusion process. J Virol 77: 4722-4730.
19. Yoshii H, Kamiyama H, Minematsu K, Goto K, Mizota T, et al. (2009) Cathepsin L is required for ecotropic murine leukemia virus infection in NIH3T3 cells. Virology 394: 227-234.
20. Kumar P, Nachagari D, Fields C, Franks J, Albritton LM, (2007) Host cell cathepsins potentiate Moloney murine leukemia virus infection. J Virol 81: 10506-10514.
21. Chandran K, Sullivan NJ, Felbor U, Whelan SP, Cunningham JM, (2005) Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 308: 1643-1645.
22. Simmons G, Gosalia DN, Rennekamp AJ, Reeves JD, Diamond SL, et al. (2005) Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc Natl Acad Sci U S A 102: 11876-11881.
23. Mori Y, Yamashita T, Tanaka Y, Tsuda Y, Abe T, et al. (2007) Processing of capsid protein by cathepsin L plays a crucial role in replication of Japanese encephalitis virus in neural and macrophage cells. J Virol 81: 8477-8487.
24. Ebert DH, Deussing J, Peters C, Dermody TS, (2002) Cathepsin L and cathepsin B mediate reovirus disassembly in murine fibroblast cells. J Biol Chem 277: 24609-24617.
25. Fredericksen BL, Wei BL, Yao J, Luo T, Garcia JV, (2002) Inhibition of endosomal/lysosomal degradation increases the infectivity of human immunodeficiency virus. J Virol 76: 11440-11446.
26. Miyauchi K, Kim Y, Latinovic O, Morozov V, Melikyan GB, (2009) HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes. Cell 137: 433-444.
27. Miyauchi K, Kozlov MM, Melikyan GB, (2009) Early steps of HIV-1 fusion define the sensitivity to inhibitory peptides that block 6-helix bundle formation. PLoS Pathog 5: e1000585.
28. Kubo Y, Yokoyama M, Yoshii H, Mitani C, Tominaga C, et al. (2007) Inhibitory role of CXCR4 glycan in CD4-independent X4-tropic human immunodeficiency virus type 1 infection and its abrogation in CD4-dependent infection. J Gen Virol 88: 3139-3144.
29. Zerhouni B, Nelson JA, Saha K, (2004) CXCR4-dependent infection of CD8+, but not CD4+, lymphocytes by a primary human immunodeficiency virus type 1 isolate. J Virol 78: 12288-12296.
30. Paraoan L, Grierson I, (2007) Focus on molecules: cystatin C. Exp Eye Res 84: 1019-1020.
31. Tsuge H, Nishimura T, Tada Y, Asao T, Turk D, et al. (1999) Inhibition mechanism of cathepsin L-specific inhibitors based on the crystal structure of papain-CLIK148 complex. Biochem Biophys Res Commun 266: 411-416.
32. Li Q, Falkler WA Jr, Bever CT Jr, (1997) Endotoxin induces increased intracellular cathepsin B activity in THP-1 cells. Immunopharmacol Immunotoxicol 19: 215-237.
33. Li JH, D'Alessio A, Pober JS, (2009) Lipopolysaccharide can trigger a cathepsin B-dependent programmed death response in human endothelial cells. Am J Pathol 175: 1124-1135.
34. Meheus LA, Fransen LM, Raymackers JG, Blockx HA, Van Beeumen JJ, et al. (1993) Identification by microsequencing of lipopolysaccharide-induced proteins secreted by mouse macrophages. J Immunol 151: 1535-1547.
35. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr, (1997) A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388: 394-397.
36. Clayton LK, Hussey RE, Steinbrich R, Ramachandran H, Husain Y, et al. (1988) Substitution of murine for human CD4 residues identifies amino acids critical for HIV-gp120 binding. Nature 335: 363-366.
37. Benmerah A, Bayrou M, Cerf-Bensussan N, Dautry-Varsat A, (1999) Inhibition of clathrin-coated pit assembly by an Eps15 mutant. J Cell Sci 112 (Pt9): 1303-1311.
38. Benmerah A, Lamaze C, Begue B, Schmid SL, Dautry-Varsat A, et al. (1998) AP-2/Eps15 interaction is required for receptor-mediated endocytosis. J Cell Biol 140: 1055-1062.
39. Macia E, Ehrlich M, Massol R, Boucrot E, Brunner C, et al. (2006) Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell 10: 839-850.
40. Potempa S, Picard L, Reeves JD, Wilkinson D, Weiss RA, et al. (1997) CD4-independent infection by human immunodeficiency virus type 2 strain ROD/B: the role of the N-terminal domain of CXCR-4 in fusion and entry. J Virol 71: 4419-4424.
41. cental Luciano-Montalvo C, Ciborowski P, Duan F, Gendelman HE, Melendez LM, (2008) Proteomic analyses associate cystatin B with restricted HIV-1 replication in placental macrophages. Placenta 29: 1016-1023.
42. Greiner A, Lautwein A, Overkleeft HS, Weber E, Driessen C, (2003) Activity and subcellular distribution of cathepsins in primary human monocytes. J Leukoc Biol 73: 235-242.
43. Puri A, Winick J, Lowy RJ, Covell D, Eidelman O, et al. (1988) Activation of vesicular stomatitis virus fusion with cells by pretreatment at low pH. J Biol Chem 263: 4749-4753.
44. Katunuma N, Matsunaga Y, Himeno K, Hayashi Y, (2003) Insights into the roles of cathepsins in antigen processing and presentation revealed by specific inhibitors. Biol Chem 384: 883-890.
45. Espagne E, Douris V, Lalmanach G, Provost B, Cattolico L, et al. (2005) A virus essential for insect host-parasite interactions encodes cystatins. J Virol 79: 9765-9776.
46. Manoury B, Gregory WF, Maizels RM, Watts C, (2001) Bm-CPI-2, a cystatin homolog secreted by the filarial parasite Brugia malayi, inhibits class II MHC-restricted antigen processing. Curr Biol 11: 447-451.
47. Newlands GF, Skuce PJ, Knox DP, Smith WD, (2001) Cloning and expression of cystatin, a potent cysteine protease inhibitor from the gut of Haemonchus contortus. Parasitology 122: 371-378.
48. Kamiyama H, Yoshii H, Tanaka Y, Sato H, Yamamoto N, et al. (2009) Raft localization of CXCR4 is primarily required for X4-tropic human immunodeficiency virus type 1 infection. Virology 386: 23-31.
49. Reeves JD, Schulz TF, (1997) The CD4-independent tropism of human immunodeficiency virus type 2 involves several regions of the envelope protein and correlates with a reduced activation threshold for envelope-mediated fusion. J Virol 71: 1453-1465.
50. Chang LJ, Urlacher V, Iwakuma T, Cui Y, Zucali J, (1999) Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system. Gene Ther 6: 715-728.
51. Vidricaire G, Tremblay MJ, (2007) A clathrin, caveolae, and dynamin-independent endocytic pathway requiring free membrane cholesterol drives HIV-1 internalization and infection in polarized trophoblastic cells. J Mol Biol 368: 1267-1283.
52. Sato H, Orenstein J, Dimitrov D, Martin M, (1992) Cell-to-cell spread of HIV-1 occurs within minutes and may not involve the participation of virus particles. Virology 186: 712-724.
53. Cosset FL, Takeuchi Y, Battini JL, Weiss RA, Collins MK, (1995) High-titer packaging cells producing recombinant retroviruses resistant to human serum. J Virol 69: 7430-7436.
54. Pear WS, Nolan GP, Scott ML, Baltimore D, (1993) Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci U S A 90: 8392-8396.
55. Subler MA, Martin DW, Deb S, (1994) Activation of the human immunodeficiency virus type 1 long terminal repeat by transforming mutants of human p53. J Virol 68: 103-110.
56. Henderson A, Holloway A, Reeves R, Tremethick DJ, (2004) Recruitment of SWI/SNF to the human immunodeficiency virus type 1 promoter. Mol Cell Biol 24: 389-397.
57. Kubo Y, Yoshii H, Kamiyama H, Tominaga C, Tanaka Y, et al. (2008) Ezrin, Radixin, and Moesin (ERM) proteins function as pleiotropic regulators of human immunodeficiency virus type 1 infection. Virology 375: 130-140.
58. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, et al. (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272: 263-267.
59. Iwakuma T, Cui Y, Chang LJ, (1999) Self-inactivating lentiviral vectors with U3 and U5 modifications. Virology 261: 120-132.
60. Tanaka R, Yoshida A, Murakami T, Baba E, Lichtenfeld J, et al. (2001) Unique monoclonal antibody recognizing the third extracellular loop of CXCR4 induces lymphocyte agglutination and enhances human immunodeficiency virus type 1-mediated syncytium formation and productive infection. J Virol 75: 11534-11543.